argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$947.52−3.43 (-0.36%)
Close on Nov 17, 2026Market cap –P/E 48.4Yield –
argenx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
argenx's pe ratio was 50.0× on Nov 11, 2026, against 71.4× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 50.0× | −15.8 |
| 2025 | Dec 31, 2025 | 65.8× | – |
See a number that looks wrong?